{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:49:55Z","timestamp":1760100595856,"version":"3.40.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T00:00:00Z","timestamp":1379462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12328-013-0425-7","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T02:16:20Z","timestamp":1379384180000},"page":"352-356","source":"Crossref","is-referenced-by-count":6,"title":["Emerging pharmacological therapy for functional dyspepsia"],"prefix":"10.1007","volume":"6","author":[{"given":"Mariko","family":"Hojo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,18]]},"reference":[{"key":"425_CR1","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","volume":"130","author":"J Tack","year":"2006","unstructured":"Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466\u201379.","journal-title":"Gastroenterology"},{"key":"425_CR2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cgh.2010.03.003","volume":"8","author":"RA Brook","year":"2010","unstructured":"Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8:498\u2013503.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"425_CR3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.gastro.2004.05.030","volume":"127","author":"J Tack","year":"2004","unstructured":"Tack J, Bisschops R, Sarnelli G. Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004;127:1239\u201355.","journal-title":"Gastroenterology"},{"key":"425_CR4","doi-asserted-by":"crossref","unstructured":"Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006:CD001960.","DOI":"10.1002\/14651858.CD001960.pub3"},{"key":"425_CR5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/archinternmed.2011.541","volume":"171","author":"P Moayyedi","year":"2011","unstructured":"Moayyedi P. Helicobacter pylori eradication for functional dyspepsia: what are we treating? comment on \u201cHelicobacter pylori eradication in functional dyspepsia\u201d. Arch Intern Med. 2011;171:1936\u20137.","journal-title":"Arch Intern Med"},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00535-005-1687-8","volume":"40","author":"M Hojo","year":"2005","unstructured":"Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, Kawabe M, et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol. 2005;40:1036\u201342.","journal-title":"J Gastroenterol"},{"key":"425_CR7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2036.2012.05011.x","volume":"35","author":"J Tack","year":"2012","unstructured":"Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35:745\u201367.","journal-title":"Aliment Pharmacol Ther"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1254\/jjp.71.129","volume":"71","author":"Y Iwanaga","year":"1996","unstructured":"Iwanaga Y, Miyashita N, Saito T, Morikawa K, Itoh Z. Gastroprokinetic effect of a new benzamide derivative itopride and its action mechanisms in conscious dogs. Jpn J Pharmacol. 1996;71:129\u201337.","journal-title":"Jpn J Pharmacol"},{"key":"425_CR9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","volume":"354","author":"G Holtmann","year":"2006","unstructured":"Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006;354:832\u201340.","journal-title":"N Engl J Med"},{"key":"425_CR10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.2007.132449","volume":"57","author":"NJ Talley","year":"2008","unstructured":"Talley NJ, Tack J, Ptak T, Gupta R, Gigu\u00e8re M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008;57:740\u20136.","journal-title":"Gut"},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2036.2010.04487.x","volume":"33","author":"E Scarpellini","year":"2011","unstructured":"Scarpellini E, Vos R, Blondeau K, Boecxstaens V, Farr\u00e9 R, Gasbarrini A, et al. The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. Aliment Pharmacol Ther. 2011;33:99\u2013105.","journal-title":"Aliment Pharmacol Ther"},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2036.2008.03849.x","volume":"28","author":"L Oudenhove Van","year":"2008","unstructured":"Van Oudenhove L, Kindt S, Vos R, Coulie B, Tack J. Influence of buspirone on gastric sensorimotor function in man. Aliment Pharmacol Ther. 2008;28:1326\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"425_CR13","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1038\/ajg.2009.427","volume":"104","author":"H Miwa","year":"2009","unstructured":"Miwa H, Nagahara A, Tominaga K, Yokoyama T, Sawada Y, Inoue K, et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol. 2009;104:2779\u201387.","journal-title":"Am J Gastroenterol"},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1540\/jsmr.36.69","volume":"36","author":"T Nakajima","year":"2000","unstructured":"Nakajima T, Nawata H, Ito Y. Z-338, a newly synthetized carboxyamide derivative, stimulates gastric motility through enhancing the excitatory neurotransmission. J Smooth Muscle Res. 2000;36:69\u201381.","journal-title":"J Smooth Muscle Res"},{"key":"425_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3565(24)39036-6","volume":"294","author":"M Ogishima","year":"2000","unstructured":"Ogishima M, Kaibara M, Ueki S, Kurimoto T, Taniyama K. Z-338 facilitates acetylcholine release from enteric neurons due to blockade of muscarinic autoreceptors in guinea pig stomach. J Pharmacol Exp Ther. 2000;294:33\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"425_CR16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.110.174847","volume":"336","author":"Y Matsunaga","year":"2011","unstructured":"Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, et al. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. J Pharmacol Exp Ther. 2011;336(3):791\u2013800.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"425_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2982.2008.01135.x","volume":"20","author":"K Seto","year":"2008","unstructured":"Seto K, Sasaki T, Katsunuma K, Kobayashi N, Tanaka K, Tack J. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats. Neurogastroenterol Motil. 2008;20(9):1051\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"425_CR18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","volume":"21","author":"J Tack","year":"2009","unstructured":"Tack J, Masclee A, Heading R, Berstad A, Piessevaux H, Popiela T, et al. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol Motil. 2009;21(3):272\u201380.","journal-title":"Neurogastroenterol Motil"},{"key":"425_CR19","doi-asserted-by":"crossref","unstructured":"Matsueda K, Hongo M, Tack J, Aoki H, Saito Y, Kato H. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia-100\u00a0mg t.i.d. is an optimal dosage. Neurogastroenterol Motil 2010;22(6):618\u2013e173.","DOI":"10.1111\/j.1365-2982.2009.01449.x"},{"issue":"6","key":"425_CR20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/gutjnl-2011-301454","volume":"61","author":"K Matsueda","year":"2012","unstructured":"Matsueda K, Hongo M, Tack J, Saito Y, Kato H. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012;61(6):821\u20138.","journal-title":"Gut"},{"key":"425_CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.1993.tb00120.x","volume":"7","author":"M Tatsuta","year":"1993","unstructured":"Tatsuta M, Iishi H. Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther. 1993;7:459\u201362.","journal-title":"Aliment Pharmacol Ther"},{"key":"425_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1254\/jphs.FPJ04056X","volume":"98","author":"T Kido","year":"2005","unstructured":"Kido T, Nakai Y, Kase Y, Sakakibara I, Nomura M, Takeda S, et al. Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-l-arginine. J Pharmacol Sci. 2005;98:161\u20137.","journal-title":"J Pharmacol Sci"},{"key":"425_CR23","first-page":"211","volume":"25","author":"T Hayakawa","year":"1999","unstructured":"Hayakawa T, Arakawa T, Kase Y, Akiyama S, Ishige A, Takeda S, et al. Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res. 1999;25:211\u20138.","journal-title":"Drugs Exp Clin Res"},{"key":"425_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0300-9629(95)02061-6","volume":"113","author":"Y Goso","year":"1996","unstructured":"Goso Y, Ogata Y, Ishihara K, Hotta K. Effects of traditional herbal medicine on gastric mucin against ethanol-induced gastric injury in rats. Comp Biochem Physiol C. 1996;113:17\u201321.","journal-title":"Comp Biochem Physiol C"},{"issue":"7","key":"425_CR25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1053\/j.gastro.2008.02.078","volume":"134","author":"H Takeda","year":"2008","unstructured":"Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, et al. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology. 2008;134(7):2004\u201313.","journal-title":"Gastroenterology"},{"issue":"113","key":"425_CR26","first-page":"62","volume":"59","author":"M Arai","year":"2012","unstructured":"Arai M, Matsumura T, Tsuchiya N, Sadakane C, Inami R, Suzuki T, et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology. 2012;59(113):62\u20136.","journal-title":"Hepatogastroenterology"},{"key":"425_CR27","first-page":"97","volume":"37","author":"H Kusunoki","year":"2011","unstructured":"Kusunoki H, Tsukamoto M, Yamashita N, Honda K, Inoue K. The traditional Japanese Medicine (Kampo) in treating functional dyspepsia. Kawasaki Med J. 2011;37:97\u2013106.","journal-title":"Kawasaki Med J"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-013-0425-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-013-0425-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-013-0425-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T14:42:04Z","timestamp":1746024124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-013-0425-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,18]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s12328-013-0425-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2013,9,18]]}}}